Crossmark

Pharmacogenomic biomarker information on drug labels of the Spanish Agency of Medicines and Sanitary products: evaluation and comparison with other regulatory agencies

Crossref DOI link: https://doi.org/10.1038/s41397-023-00321-y

Published Online: 2024-01-17

Published Print: 2024-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Estévez-Paredes, María https://orcid.org/0000-0002-7096-7749
Mata-Martín, M. Carmen https://orcid.org/0000-0002-1849-1093
de Andrés, Fernando https://orcid.org/0000-0003-1076-0743
LLerena, Adrián https://orcid.org/0000-0002-5663-7081
Funding

Funding for this research was provided by:

Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (PMP22/00099, IMP/000009)

Agencia Española de Medicamentos y Productos Sanitarios
License Information

Text and Data Mining valid from 2024-01-17

Version of Record valid from 2024-01-17
More Information

Article History

Received: 7 March 2023

Revised: 7 October 2023

Accepted: 5 December 2023

First Online: 17 January 2024

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below